HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Skin Devices Poised To Tap “Wealth Of Unrealized Potential” – Kline

This article was originally published in The Rose Sheet

Executive Summary

Pricing products more economically and expanding distribution are challenges for skin-care device marketers, but there is significant opportunity for firms that can reach consumers at the mass retail level, says Kline & Company. The market for home-use aesthetic devices grew globally by 22% in 2012.

You may also be interested in...



IlluMask Devices Combat Acne, Aging At $1 Per Treatment

The market for light-based skin-care devices for consumer use at home grows with the introduction of La Lumiere’s illuMask. Available in anti-acne and anti-aging variants, the LED-equipped mask is priced at $30 for 30 treatments.

In Brief: Coty Reports Q2 Declines; Arden, IFF Make R&D Investments; More

Elizabeth Arden and International Flavors and Fragrances invest in a beauty device and “next-generation” encapsulation technology for hair and personal wash applications, respectively. More news in brief.

Anti-Aging Will Drive Personal-Care Growth For Next Five Years – Kline

At the recent Happi Anti-Aging Conference in New Brunswick, N.J., Kline Group industry manager Nancy Mills discussed the anti-aging market and the market research firm’s latest findings and predictions for the popular segment of the personal-care industry.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018615

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel